PrimeRFP SCOUT · Federal Contract Recompete Brief

36C26123A0014EO 14398 requirement — Progenics Pharmaceuticals, Inc

Progenics Pharmaceuticals, Inc holds $95.0M across 149 federal awards, concentrated at Department of Veterans Affairs (VA). This PIID sits alongside 5 related awards in the incumbent pipeline. Set-aside status: SBA.

261-Network Contract Office 21 (36C261)
Awarding office
Progenics Pharmaceuticals, Inc
Recipient
Estimated value
6505
PSC
SBA
Set-aside

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Progenics Pharmaceuticals, Inc — $90

Contract facts

SBA
Contract number36C26123A0014
Also listed as36C261-23-A-0014
Agency261-Network Contract Office 21 (36C261)
Awarding office261-Network Contract Office 21 (36C261)
Awarding agencyDepartment of Veterans Affairs (VA)
Funding agencyDepartment of Veterans Affairs (VA)
IncumbentProgenics Pharmaceuticals, Inc
UEIYLYKVRPCTCR3
PSC6505
Related solicitation36C26123Q0135

EO 14398 REQUIREMENT. is a federal SBA award for 261-Network Contract Office 21 (36C261) held by Progenics Pharmaceuticals, Inc. Estimated value —. Related solicitation 36C26123Q0135.

Incumbent footprint

Public record

Progenics Pharmaceuticals, Inc$95.0M obligated across 149 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).

% of firm-wide obligated ($95.0M) · all agencies
Department of Veterans Affairs (VA)$93.8M · 99%Department of Health and Human Services (HHS)$1.1M · 1%Department of Defense (DOD)$105K · 0%
Open full company profile

Related awards

Same incumbent
36C24625N1142
PYLARIFY F-18 INJECTIONS (336)
$1.2M
Aug 31, 2026
75N90025F00021
PIFLUFOLASTAT F-18 INJECTION DRUGS (PYLARIFY) FROM SOFIE CO.:1108959 [25-004297]
$611K
Sep 25, 2026
36C26126N0023
480 F18 PYLARIFY DOSES POP 1/1/2025 - 12/31/2025
$1.7M
Sep 26, 2026
75N90025F00003
PIFLUFOLASTAT F-18 INJECTION DRUGS (PYLARIFY) FROM SOFIE CO. [POTS 25-000073]
$2.1M
Sep 29, 2026
36C26122N0385
PYLARIFY (PIFLUFOLASTAT F18) NDC: 71258-0022-01
$4.5M
Sep 30, 2026

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP

More in SCOUT
Size up the competition →Research the incumbent →

Frequently asked questions

What is contract 36C26123A0014?

36C26123A0014 (EO 14398 requirement) is a 261-Network Contract Office 21 (36C261) award with an estimated value of —, currently held by Progenics Pharmaceuticals, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is 36C261-23-A-0014?

36C261-23-A-0014 is the dashed form of PIID 36C26123A0014 (EO 14398 requirement), held by Progenics Pharmaceuticals, Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded 36C26123A0014?

261-Network Contract Office 21 (36C261) awarded 36C26123A0014 to Progenics Pharmaceuticals, Inc.

Who is the incumbent on 36C26123A0014?

Progenics Pharmaceuticals, Inc is the incumbent with $95.0M across 149 related awards in SCOUT’s public footprint.

When does Progenics Pharmaceuticals, Inc’s 36C26123A0014 come up for recompete?

SCOUT tracks a period-of-performance end of an unstated date. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of · refreshed monthly
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/36C26123A0014